Archive Newsletter
-
05.08.25 -- Upskilling Your Quality Team For The AI Revolution In Pharma 4.0
5/8/2025
05/08/25 Cell & Gene Newsletter
-
05.07.25 -- Ensure Batch Reproducibility With Easy-To-Use PAT Tools
5/7/2025
05/07/25 Cell & Gene Newsletter
-
05.07.25 -- Lean Thinking For Pharma — Flow Without Facility Upheaval
5/7/2025
05/07/25 Cell & Gene Newsletter
-
05.06.25 -- Revolutionizing T-Cell Lymphoma Treatment Through Cell Therapy, Manufacturing
5/6/2025
05/06/25 Cell & Gene Newsletter
-
05.06.25 -- STREAM Edition: Optimizing Storage Solutions For iPSCs
5/6/2025
05/06/25 Cell & Gene Newsletter
-
05.06.25 -- Why Pharma Risk Assessments Should Include 'Working Together Alone'
5/6/2025
05/06/25 Cell & Gene Newsletter
-
05.05.25 -- Navigating Cell And Gene Therapy Clinical Trials
5/5/2025
05/05/25 Cell & Gene Newsletter
-
05.05.25 -- What CDMOs Wish Biotechs Knew Before Submitting An RFP
5/5/2025
05/05/25 Cell & Gene Newsletter
-
05.02.25 -- New Podcast Episodes: China's Growth, Investment Trends, NIH Cuts, and more
5/2/2025
05/02/25 Cell & Gene Newsletter
-
05.02.25 -- Critical Factors For Early Phase Clinical Trials, Dose Selection, And AAV Capsid Engineering
5/2/2025
05/02/25 Cell & Gene Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more